Endoscopic treatments of obesity: a comprehensive review

Surgery for Obesity and Related Diseases

Volumn 12, Issue 5, 2016, Pages 1108-1115

  Neylan, Christopher J ^a   Dempsey, Daniel T ^a   Tewksbury, Colleen M ^a   Williams, Noel N ^a   Dumon, Kristoffel R ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bariatric surgery; Endoscopy; Obesity

Indexed keywords

BOTULINUM TOXIN A;

ARTICULATING CIRCULAR ENDOSCOPIC STAPLING; ASPIRATION THERAPY; DEVICE REMOVAL; DIGESTIVE SURGICAL DEVICE; DUODENAL MUCOSAL RESURFACING; ELECTROSTIMULATION; ENDOSCOPIC GASTROPLASTY; ENDOSCOPIC SLEEVE GASTROPLASTY; ENDOSCOPIC SURGERY; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GASTRIC BALLOON; GASTRIC SLEEVE; GASTRODUODENOJEJUNAL BYPASS SLEEVE; GASTROILEOSTOMY; GASTROINTESTINAL STAPLER; GASTROJEJUNOSTOMY; GASTROPLASTY; HUMAN; ILEOSTOMY; LONG TERM CARE; MAGNETIC COMPRESSION ANASTOMOSIS; MEDICAL SUBJECT HEADINGS; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); OBESITY; PRIMARY OBESITY SURGERY ENDOLUMINAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESURFACING DEVICE; REVIEW; STOMACH BYPASS DEVICE; STOMACH TUBE; SURGICAL STAPLING; SUTURE ANCHOR; THROMBECTOMY CATHETER; TRANSORAL GASTROPLASTY; UNITED STATES; UNIVERSITY HOSPITAL; WEIGHT REDUCTION; BARIATRIC SURGERY; DEVICE APPROVAL; DEVICES; ELECTROTHERAPY; EQUIPMENT DESIGN; GASTROINTESTINAL ENDOSCOPY; PROCEDURES; TREATMENT OUTCOME;

BARIATRIC SURGERY; DEVICE APPROVAL; ELECTRIC STIMULATION THERAPY; ENDOSCOPY, GASTROINTESTINAL; EQUIPMENT DESIGN; GASTRIC BALLOON; HUMANS; OBESITY; SURGICAL STAPLING; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84991768955     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2016.02.006     Document Type: Review

References (43)

1. Ogden, C.L., Carroll, M.D., Kit, B.K., Flegal, K.M., Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311:8 (2014), 806–814.
2. Gloy, V.L., Briel, M., Bhatt, D.L., et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ, 347, 2013, f5934.
3. Abu-Dayyeh, B.K., Sarmiento, R., Rajan, E., Vazquez-Sequeiros, E., Gostout, C.J., Endoscopic treatments of obesity and metabolic disease: are we there yet?. Rev Esp Enferm Dig 106:7 (2014), 467–476.
4. U.S. Food and Drug Administration. Medical devices cleared or approved by FDA in 2015. U.S. Department of Health and Human Services [cited 2015 Oct 23]. Available from: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm430692.htm.
5. Kumar, N., Endoscopic therapy for weight loss: gastroplasty, duodenal sleeves, intragastric balloons, and aspiration. World J Gastrointest Endosc 7:9 (2015), 847–859.
6. ASGE Bariatric Endoscopy Task Force, ASGE Technology Committee, Abu Dayyeh, B.K., et al. Endoscopic bariatric therapies. Gastrointest Endosc 81:5 (2015), 1073–1086.
7. Ozturk, A., Akinci, O.F., Kurt, M., Small intestinal obstruction due to self-deflated free intragastric balloon. Surg Obes Relat Dis 6:5 (2010), 569–571.
8. Al-Zubaidi, A.M., Alghamdi, H.U., Alzobydi, A.H., Dhiloon, I.A., Qureshi, L.A., Bowel perforation due to break and distal passage of the safety ring of an adjustable intra-gastric balloon: a potentially life threatening situation. World J Gastrointest Endosc 7:4 (2015), 429–432.
9. Ozturk, A., Yavuz, Y., Atalay, T., A case of duodenal obstruction and pancreatitis due to intragastric galloon. Balkan Med J 32:3 (2015), 323–326.
10. Alfredo, G., Roberta, M., Francesca, F., et al. Intragastric balloon for obesity treatment: results of a multicentric evaluation for balloons left in place for more than 6 months. Surg Endosc 29:8 (2015), 2339–2343.
11. Lopez-Nava, G., Bautista-Castano, I., Jimenez-Banos, A., Fernandez-Corbelle, J.P., Dual intragastric balloon: single ambulatory center Spanish experience with 60 patients in endoscopic weight loss management. Obes Surg 25:12 (2015), 2263–2267.
12. Ponce, J., Quebbemann, B.B., Patterson, E.J., Prospective, randomized, multicenter study evaluating safety and efficacy of intragastric dual-balloon in obesity. Surg Obes Relat Dis 9:2 (2013), 290–2905.
13. Kotzampassi, K., Grosomanidis, V., Papakostas, P., Penna, S., Eleftheriadis, E., 500 intragastric balloons: what happens 5 years thereafter?. Obes Surg 22:6 (2012), 896–903.
14. Imaz, I., Martinez-Cervell, C., Garcia-Alvarez, E.E., Sendra-Gutierrez, J.M., Gonzalez-Enriquez, J., Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg 18:7 (2008), 841–846.
15. Dumonceau, J.M., Francois, E., Hittelet, A., Mehdi, A.I., Barea, M., Deviere, J., Single vs repeated treatment with the intragastric balloon: a 5-year weight loss study. Obes Surg 20:6 (2010), 692–697.
16. Zerrweck, C., Maunoury, V., Caiazzo, R., et al. Preoperative weight loss with intragastric balloon decreases the risk of significant adverse outcomes of laparoscopic gastric bypass in super-super obese patients. Obes Surg 22:5 (2012), 777–782.
17. Forlano, R., Ippolito, A.M., Iacobellis, A., et al. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc 71:6 (2010), 927–933.
18. Tai, C.M., Lin, H.Y., Yen, Y.C., et al. Effectiveness of intragastric balloon treatment for obese patients: one-year follow-up after balloon removal. Obes Surg 23:12 (2013), 2068–2074.
19. Deliopoulou, K., Konsta, A., Penna, S., Papakostas, P., Kotzampassi, K., The impact of weight loss on depression status in obese individuals subjected to intragastric balloon treatment. Obes Surg 23:5 (2013), 669–675.
20. Obeid, N.R., Malick, W., Concors, S.J., Fielding, G.A., Kurian, M.S., Ren-Fielding, C.J., Long-term outcomes after Roux-en-Y gastric bypass: 10- to 13-year data. Surg Obes Relat Dis 12:1 (2016), 11–20.
21. Ponce, J., Woodman, G., Swain, J., et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis 11:4 (2015), 874–881.
22. Marinos, G., Eliades, C., Raman Muthusamy, V., Greenway, F., Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study. Surg Obes Relat Dis 10:5 (2014), 929–934.
23. Sauer, N., Rosch, T., Pezold, J., et al. A new endoscopically implantable device (SatiSphere) for treatment of obesity-efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels. Obes Surg 23:11 (2013), 1727–1733.
24. Abu Dayyeh, B.K., Rajan, E., Gostout, C.J., Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc 78:3 (2013), 530–535.
25. Lopez-Nava, G., Galvao, M.P., da Bautista-Castano, I., Jimenez, A., De Grado, T., Fernandez-Corbelle, J.P., Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy 47:5 (2015), 449–452.
26. Mathus-Vliegen, E.M., Endoscopic treatment: the past, the present and the future. Best Pract Res Clin Gastroenterol 28:4 (2014), 685–702.
27. Lopez-Nava, G., Bautista-Castano, I., Jimenez, A., de Grado, T., Fernandez-Corbelle, J.P., The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis 11:4 (2015), 861–865.
28. Koehestanie, P., de Jonge, C., Berends, F.J., Janssen, I.M., Bouvy, N.D., Greve, J.W., The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann Surg 260:6 (2014), 984–992.
29. Fogel, R., De Fogel, J., Bonilla, Y., De La Fuente, R., Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc 68:1 (2008), 51–58.
30. Brethauer, S.A., Chand, B., Schauer, P.R., Thompson, C.C., Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial. Surg Obes Relat Dis 8:3 (2012), 296–303.
31. Familiari, P., Costamagna, G., Blero, D., et al. Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome. Gastrointest Endosc 74:6 (2011), 1248–1258.
32. Verlaan, T., Paulus, G.F., Mathus-Vliegen, E.M., et al. Endoscopic gastric volume reduction with a novel articulating plication device is safe and effective in the treatment of obesity (with video). Gastrointest Endosc 81:2 (2015), 312–320.
33. GI Dynamics. ENDO Trial placed on enrollment hold [updated 2015 Mar 5; cited 2016 Jan 20]. Available from: http://www.gidynamics.com/media-press-release.php?id=139.
34. Sandler, B.J., Rumbaut, R., Swain, C.P., et al. One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity. Surg Endosc 29:11 (2015), 3298–3303.
35. Zhang, Y., Du, S., Fang, L., Yao, S., Chen, J.D., Retrograde gastric electrical stimulation suppresses calorie intake in obese subjects. Obesity (Silver Spring) 22:6 (2014), 1447–1451.
36. Behary, J., Kumbhari, V., Advances in the endoscopic management of obesity. Gastroenterol Res Pract, 2015, 2015, 757821.
37. Forssell, H., Noren, E., A novel endoscopic weight loss therapy using gastric aspiration: results after 6 months. Endoscopy 47:1 (2015), 68–71.
38. Kumbhari, V., Oberbach, A., Nimgaonkar, A., Primary endoscopic therapies for obesity and metabolic diseases. Curr Opin Gastroenterol 31:5 (2015), 351–358.
39. Bang, C.S., Baik, G.H., Shin, I.S., et al. Effect of intragastric injection of botulinum toxin A for the treatment of obesity: a meta-analysis and meta-regression. Gastrointest Endosc 81:5 (2015), 1141–1149 e1–7.
40. ASGE Bariatric Endoscopy Task Force, ASGE Technology Committee, Abu Dayyeh, B.K., et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 82:3 (2015), 425–438 e5.
41. ASGE/ASMBS Task Force on Endoscopic Bariatric Therapy. A pathway to endoscopic bariatric therapies. Surg Obes Relat Dis 7:6 (2011), 672–682.
42. Yanovski, S.Z., Yanovski, J.A., Long-term drug treatment for obesity: a systematic and clinical review. JAMA 311:1 (2014), 74–86.
43. van de Laar, A., de Caluwe, L., Dillemans, B., Relative outcome measures for bariatric surgery. Evidence against excess weight loss and excess body mass index loss from a series of laparoscopic Roux-en-Y gastric bypass patients. Obes Surg 21:6 (2011), 763–767.